IL92961A0 - Anti-inflammatory 1-heteroarylox-indole-3-carboxamides - Google Patents

Anti-inflammatory 1-heteroarylox-indole-3-carboxamides

Info

Publication number
IL92961A0
IL92961A0 IL92961A IL9296190A IL92961A0 IL 92961 A0 IL92961 A0 IL 92961A0 IL 92961 A IL92961 A IL 92961A IL 9296190 A IL9296190 A IL 9296190A IL 92961 A0 IL92961 A0 IL 92961A0
Authority
IL
Israel
Prior art keywords
furyl
thienyl
alkyl
indole
heteroarylox
Prior art date
Application number
IL92961A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL92961A0 publication Critical patent/IL92961A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Indole Compounds (AREA)
IL92961A 1989-01-10 1990-01-03 Anti-inflammatory 1-heteroarylox-indole-3-carboxamides IL92961A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1989/000080 WO1990008146A1 (en) 1989-01-10 1989-01-10 Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides

Publications (1)

Publication Number Publication Date
IL92961A0 true IL92961A0 (en) 1990-09-17

Family

ID=22214773

Family Applications (1)

Application Number Title Priority Date Filing Date
IL92961A IL92961A0 (en) 1989-01-10 1990-01-03 Anti-inflammatory 1-heteroarylox-indole-3-carboxamides

Country Status (20)

Country Link
US (1) US5128352A (da)
EP (1) EP0378357B1 (da)
JP (1) JPH0678337B2 (da)
KR (1) KR920006784B1 (da)
AT (1) ATE100096T1 (da)
AU (1) AU616090B2 (da)
CA (1) CA2007651C (da)
DE (1) DE69005833T2 (da)
DK (1) DK0378357T3 (da)
ES (1) ES2062318T3 (da)
FI (1) FI94247C (da)
HU (1) HU217072B (da)
IE (1) IE61796B1 (da)
IL (1) IL92961A0 (da)
MY (1) MY106261A (da)
NO (1) NO178193C (da)
NZ (1) NZ232038A (da)
PT (1) PT92801B (da)
WO (1) WO1990008146A1 (da)
ZA (1) ZA90140B (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136839A (en) * 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
SI3240785T1 (sl) * 2014-12-29 2021-11-30 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH Malomolekulski zaviralci laktat dehidrogenaze in postopki za uporabo le-teh

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
US4176191A (en) * 1977-09-06 1979-11-27 Abbott Laboratories Aminomethylene oxindoles
US4476307A (en) * 1982-09-20 1984-10-09 Pfizer Inc. Heteroylidene indolone compounds
EP0153818B1 (en) * 1984-02-07 1989-03-15 Pfizer Inc. 1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
HU203350B (en) * 1984-08-24 1991-07-29 Pfizer Process for producing antiinflammatory tricyclic oxindole derivatives
US4686224A (en) * 1984-10-31 1987-08-11 Pfizer Inc. Oxindole antiinflammatory agents
US4644005A (en) * 1984-10-31 1987-02-17 Pfizer Inc. Oxindole antiinflammatory agents
US4791129A (en) * 1987-01-20 1988-12-13 Pfizer Inc. 1,3-dicarboxamidooxindoles as analgesic and antiinflammatory agents

Also Published As

Publication number Publication date
WO1990008146A1 (en) 1990-07-26
KR920006784B1 (ko) 1992-08-17
NO178193C (no) 1996-02-07
EP0378357A1 (en) 1990-07-18
JPH0678337B2 (ja) 1994-10-05
AU4781790A (en) 1990-07-19
JPH02247174A (ja) 1990-10-02
FI94247C (fi) 1995-08-10
KR900011763A (ko) 1990-08-02
AU616090B2 (en) 1991-10-17
HU217072B (hu) 1999-11-29
CA2007651A1 (en) 1991-07-12
DK0378357T3 (da) 1994-02-14
PT92801A (pt) 1990-07-31
FI94247B (fi) 1995-04-28
IE900074L (en) 1990-07-10
CA2007651C (en) 1997-08-19
MY106261A (en) 1995-04-29
EP0378357B1 (en) 1994-01-12
ZA90140B (en) 1991-08-28
DE69005833D1 (de) 1994-02-24
PT92801B (pt) 1995-12-29
DE69005833T2 (de) 1994-04-28
HUT58084A (en) 1992-01-28
ES2062318T3 (es) 1994-12-16
NO912696D0 (no) 1991-07-09
NO912696L (no) 1991-07-09
NO178193B (no) 1995-10-30
IE61796B1 (en) 1994-11-30
NZ232038A (en) 1991-06-25
US5128352A (en) 1992-07-07
FI913325A0 (fi) 1991-07-09
ATE100096T1 (de) 1994-01-15

Similar Documents

Publication Publication Date Title
IL129416A0 (en) New heterocyclylmethyl-substituted pyrazol derivatives
DE60026404D1 (de) Verfahren zur Herstellung von Benzothiophen-Derivaten
NZ514037A (en) 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of CNS disorders
CA2238410A1 (en) Novel indole-2,3-dione-3-oxime derivatives
FI964914A0 (fi) 2-amino-3-aroyylibentso/beta/tiofeenejä ja menetelmä niiden valmistamiseksi
CA2443868A1 (en) 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
IL92961A0 (en) Anti-inflammatory 1-heteroarylox-indole-3-carboxamides
BR9503775A (pt) Compostos e composição farmacêutica útil como um agente analgésico antiinflamatório diurético ou neuroprotetor
FI913324A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1-heteroaryyli-3-asyyli-2-oksindolijohdannaisten valmistamiseksi
GB1296112A (da)
FR2791676B1 (fr) Nouveaux derives de [(2-substitue-5-[thienyl])-benzyl]- [2-([isopropoxy-5-fluoro]-phenoxy) ethyl]-amine, leur procede de preparation et leur utilisation a titre de medicaments
WO1996025933A3 (en) Use of vinyl carboxylic acid compounds for the treatment or prevention of transient ischaemic attacks
ES8304996A1 (es) "procedimiento para la preparacion de nuevas cefalosporinas".

Legal Events

Date Code Title Description
KB Patent renewed
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees